15 results on '"Alessandro Reggiani"'
Search Results
2. Molecular Typing of Leishmania spp. Causing Tegumentary Leishmaniasis in Northeastern Italy, 2014–2020
- Author
-
Tommaso Gritti, Elena Carra, Gert Van der Auwera, José Carlos Solana, Valeria Gaspari, Silvana Trincone, Margherita Ortalli, Alice Rabitti, Alessandro Reggiani, Gianluca Rugna, Stefania Varani, and The Skin_Leish_RER Network
- Subjects
Leishmania ,heat shock protein 70 ,tegumentary leishmaniasis ,sequencing ,whole genome sequencing ,Medicine - Abstract
Tegumentary leishmaniasis (TL) is endemic but neglected in southern Europe. Therefore, this study aimed to analyze the Leishmania strains causing TL cases in northeastern Italy, where an upsurge of TL cases has been observed in the last decade. Sections from 109 formalin-fixed and paraffin-embedded (FFPE) biopsies of skin and mucosal tissues were collected from TL cases in the selected area. Two DNA targets were amplified and sequenced: the ribosomal internal transcribed spacer 1 (ITS1) and the heat-shock protein 70 gene (hsp70). An in silico analysis was also performed on 149 genomes belonging to the Leishmania donovani complex. A total of 88 out of 109 (80.7%) samples from 83 TL cases were successfully typed by ITS1 and/or hsp70. ITS1 analysis identified L. infantum in 67 cases (91.8%), while L. major (n = 4, 5.5%) and L. tropica (n = 2, 2.7%) were detected in the remaining cases that were categorized as imported. Further, the hsp70 typing of 75 autochthonous cases showed the presence of eight distinct sequence variants belonging to the Leishmania donovani complex, with high genetic variability when compared to known L. infantum populations. In conclusion, our findings show that peculiar L. infantum variants are emerging in the novel focus on TL in northeastern Italy.
- Published
- 2023
- Full Text
- View/download PDF
3. SARS-CoV-2 and animals, a long story that doesn't have to end now: What we need to learn from the emergence of the Omicron variant
- Author
-
Alessandro Reggiani, Gianluca Rugna, and Paolo Bonilauri
- Subjects
SARS-CoV-2 ,wildlife ,surveillance ,diagnostic test ,evolution ,spillover ,Veterinary medicine ,SF600-1100 - Abstract
OIE, the world organization for animal health, recently released an update on the state of the art of knowledge regarding SARS-CoV-2 in animals. For farmed animals, ferrets and minks were found to be highly susceptible to the virus and develop symptomatic disease both in natural conditions and in experimental infections. Lagomorphs of the species Oryctolagus cuniculus are indicated as highly susceptible to the virus under experimental conditions, but show no symptoms of the disease and do not transmit the virus between conspecifics, unlike raccoon dogs (Nyctereutes procyonoides), which in addition to being highly susceptible to the virus under experimental conditions, can also transmit the virus between conspecifics. Among felines, the circulation of the virus has reached a level of cases such as sometimes suggests the experimental use of vaccines for human use or treatments with monoclonal antibodies. But even among wild animals, several species (White-tailed deer, Egyptian rousettes, and minks) have now been described as potential natural reservoirs of the virus. This proven circulation of SARS-CoV-2 among animals has not been accompanied by the development of an adequate surveillance system that allows following the evolution of the virus among its natural hosts. This will be all the more relevant as the surveillance system in humans inevitably drops and we move to surveillance by sentinels similar to the human flu virus. The lesson that we can draw from the emergence of Omicron and, more than likely, its animal origin must not be lost, and in this mini-review, we explain why.
- Published
- 2022
- Full Text
- View/download PDF
4. Wildlife Hosts of Leishmania infantum in a Re-Emerging Focus of Human Leishmaniasis, in Emilia-Romagna, Northeast Italy
- Author
-
Roberta Taddei, Arianna Bregoli, Giorgio Galletti, Elena Carra, Laura Fiorentini, Maria Cristina Fontana, Matteo Frasnelli, Carmela Musto, Giovanni Pupillo, Alessandro Reggiani, Annalisa Santi, Arianna Rossi, Marco Tamba, Mattia Calzolari, and Gianluca Rugna
- Subjects
Leishmania infantum ,reservoir ,wildlife ,artiodactyls ,roe deer ,European hare ,Medicine - Abstract
In the last decade, an upsurge of human leishmaniasis has been reported in the Emilia-Romagna region, Northeast Italy. Epidemiologic data have raised doubts about the role of dogs as the main reservoirs for Leishmania infantum. In the present study, a total of 1077 wild animals were screened for L. infantum DNA in earlobe and spleen samples from 2019 to 2022. The lymph nodes were tested only in 23 animals already positive in the earlobe and/or spleen. A total of 71 (6.6%) animals resulted positive in at least one of the sampled tissues, including 3/18 (16.7%) wolves, 6/39 (15.4%) European hares, 38/309 (12.3%) roe deer, 1/11 (9.1%) red deer, 8/146 (4.9%) wild boars, 13/319 (4.1%) red foxes, 1/54 (1.9%) porcupine, and 1/59 (1.7%) European badger. Most of the infected animals (62/71) tested positive only in the earlobe tissue, only four animals (two roe deer and two wild boars) tested positive only in the spleen, and five animals (three roe deer and two red foxes) resulted positive for both tissues. L. infantum DNA was detected in the lymph nodes of 6/23 animals. L. infantum detection occurred in all seasons associated with low real-time PCR Ct values. Further research is needed in order to clarify the role of wildlife in the re-emerging focus of leishmaniasis in Northeast Italy.
- Published
- 2022
- Full Text
- View/download PDF
5. A Functional Minigenome of Parvovirus B19
- Author
-
Alessandro Reggiani, Andrea Avati, Francesca Valenti, Erika Fasano, Gloria Bua, Elisabetta Manaresi, and Giorgio Gallinella
- Subjects
parvovirus B19 ,synthetic genome ,genetic engineering ,replicon unit ,functional complementation ,Microbiology ,QR1-502 - Abstract
Parvovirus B19 (B19V) is a human pathogenic virus of clinical relevance, characterized by a selective tropism for erythroid progenitor cells in bone marrow. Relevant information on viral characteristics and lifecycle can be obtained from experiments involving engineered genetic systems in appropriate in vitro cellular models. Previously, a B19V genome of defined consensus sequence was designed, synthesized and cloned in a complete and functional form, able to replicate and produce infectious viral particles in a producer/amplifier cell system. Based on such a system, we have now designed and produced a derived B19V minigenome, reduced to a replicon unit. The genome terminal regions were maintained in a form able to sustain viral replication, while the internal region was clipped to include only the left-side genetic set, containing the coding sequence for the functional NS1 protein. Following transfection in UT7/EpoS1 cells, this minigenome still proved competent for replication, transcription and production of NS1 protein. Further, the B19V minigenome was able to complement B19-derived, NS1-defective genomes, restoring their ability to express viral capsid proteins. The B19V genome was thus engineered to yield a two-component system, with complementing functions, providing a valuable tool for studying viral expression and genetics, suitable to further engineering for purposes of translational research.
- Published
- 2022
- Full Text
- View/download PDF
6. No G-Quadruplex Structures in the DNA of Parvovirus B19: Experimental Evidence versus Bioinformatic Predictions
- Author
-
Gloria Bua, Daniele Tedesco, Ilaria Conti, Alessandro Reggiani, Manuela Bartolini, and Giorgio Gallinella
- Subjects
parvovirus B19 ,G-quadruplex ,bioinformatics ,antivirals ,BRACO-19 ,pyridostatin ,Microbiology ,QR1-502 - Abstract
Parvovirus B19 (B19V), an ssDNA virus in the family Parvoviridae, is a human pathogenic virus, responsible for a wide range of clinical manifestations, still in need of effective and specific antivirals. DNA structures, including G-quadruplex (G4), have been recognised as relevant functional features in viral genomes, and small-molecule ligands binding to these structures are promising antiviral compounds. Bioinformatic tools predict the presence of potential G4 forming sequences (PQSs) in the genome of B19V, raising interest as targets for antiviral strategies. Predictions locate PQSs in the genomic terminal regions, in proximity to replicative origins. The actual propensity of these PQSs to form G4 structures was investigated by circular dichroism spectroscopic analysis on synthetic oligonucleotides of corresponding sequences. No signature of G4 structures was detected, and the interaction with the G4 ligand BRACO-19 (N,N′-(9-{[4-(dimethylamino)phenyl]amino}acridine-3,6-diyl)bis(3-pyrrolidin-1-ylpropanamide) did not appear consistent with the stabilisation of G4 structures. Any potential role of PQSs in the viral lifecycle was then assessed in an in vitro infection model system, by evaluating any variation in replication or expression of B19V in the presence of the G4 ligands BRACO-19 and pyridostatin. Neither showed a significant inhibitory activity on B19V replication or expression. Experimental challenge did not support bioinformatic predictions. The terminal regions of B19V are characterised by relevant sequence and symmetry constraints, which are functional to viral replication. Our experiments suggest that these impose a stringent requirement prevailing over the propensity of forming actual G4 structures.
- Published
- 2020
- Full Text
- View/download PDF
7. Wildlife Hosts of
- Author
-
Roberta, Taddei, Arianna, Bregoli, Giorgio, Galletti, Elena, Carra, Laura, Fiorentini, Maria Cristina, Fontana, Matteo, Frasnelli, Carmela, Musto, Giovanni, Pupillo, Alessandro, Reggiani, Annalisa, Santi, Arianna, Rossi, Marco, Tamba, Mattia, Calzolari, and Gianluca, Rugna
- Abstract
In the last decade, an upsurge of human leishmaniasis has been reported in the Emilia-Romagna region, Northeast Italy. Epidemiologic data have raised doubts about the role of dogs as the main reservoirs for
- Published
- 2022
8. No G-Quadruplex Structures in the DNA of Parvovirus B19: Experimental Evidence versus Bioinformatic Predictions
- Author
-
Ilaria Conti, Giorgio Gallinella, Alessandro Reggiani, Manuela Bartolini, Gloria Bua, Daniele Tedesco, Bua G., Tedesco D., Conti I., Reggiani A., Bartolini M., and Gallinella G.
- Subjects
Antivirals, Bioinformatics, BRACO 19, G quadruplex, Parvovirus B19, Pyridostatin ,0301 basic medicine ,Circular dichroism ,030106 microbiology ,lcsh:QR1-502 ,Computational biology ,Genome, Viral ,G-quadruplex ,Virus Replication ,Genome ,pyridostatin ,Antiviral Agents ,lcsh:Microbiology ,Virus ,Article ,NO ,03 medical and health sciences ,chemistry.chemical_compound ,antivirals ,Virology ,Parvovirus B19, Human ,Humans ,Antiviral ,BRACO-19 ,Picolinic Acids ,Cells, Cultured ,Bioinformatic ,Erythroid Precursor Cells ,biology ,parvovirus B19 ,Parvovirus ,Chemistry ,Oligonucleotide ,Circular Dichroism ,Computational Biology ,BRACO 19 ,bioinformatics ,biology.organism_classification ,G-Quadruplexes ,030104 developmental biology ,Infectious Diseases ,Viral replication ,G quadruplex ,DNA, Viral ,Aminoquinolines ,Acridines ,DNA - Abstract
Parvovirus B19 (B19V), an ssDNA virus in the family Parvoviridae, is a human pathogenic virus, responsible for a wide range of clinical manifestations, still in need of effective and specific antivirals. DNA structures, including G-quadruplex (G4), have been recognised as relevant functional features in viral genomes, and small-molecule ligands binding to these structures are promising antiviral compounds. Bioinformatic tools predict the presence of potential G4 forming sequences (PQSs) in the genome of B19V, raising interest as targets for antiviral strategies. Predictions locate PQSs in the genomic terminal regions, in proximity to replicative origins. The actual propensity of these PQSs to form G4 structures was investigated by circular dichroism spectroscopic analysis on synthetic oligonucleotides of corresponding sequences. No signature of G4 structures was detected, and the interaction with the G4 ligand BRACO-19 (N,N&prime, (9-{[4-(dimethylamino)phenyl]amino}acridine-3,6-diyl)bis(3-pyrrolidin-1-ylpropanamide) did not appear consistent with the stabilisation of G4 structures. Any potential role of PQSs in the viral lifecycle was then assessed in an in vitro infection model system, by evaluating any variation in replication or expression of B19V in the presence of the G4 ligands BRACO-19 and pyridostatin. Neither showed a significant inhibitory activity on B19V replication or expression. Experimental challenge did not support bioinformatic predictions. The terminal regions of B19V are characterised by relevant sequence and symmetry constraints, which are functional to viral replication. Our experiments suggest that these impose a stringent requirement prevailing over the propensity of forming actual G4 structures.
- Published
- 2020
9. A controlled randomised trial of t-UDCA as adjuvant to interferon for treatment of chronic hepatitis C: an interferon sparing effect of t-UDCA
- Author
-
Gracielle, Pigozzi Marie, Roberta, Sorbara, Ornella, Baisini, Luciana, Di Stefano, Alessandro, Reggiani, Daniela, Quattrocchi, Gianpaolo, Lorini, Grazia, De Tavonatti Maria, Lamberto, Bettini, Anna, Cominotti, Maurizio, Favret, and Alberto, Lanzini
- Published
- 2002
- Full Text
- View/download PDF
10. Lung inflammation in preterm infants with respiratory distress syndrome: Effects of ventilation with different tidal volumes
- Author
-
Gianluca Lista, Alessandro Reggiani, Silvia Bianchi, Francesca Castoldi, Roberta Reali, Gilberto Compagnoni, and P. Fontana
- Subjects
Pulmonary and Respiratory Medicine ,Time Factors ,medicine.medical_treatment ,Lung injury ,Positive-Pressure Respiration ,Tidal Volume ,medicine ,Humans ,Lung ,Tidal volume ,Mechanical ventilation ,Respiratory Distress Syndrome, Newborn ,Respiratory distress ,Tumor Necrosis Factor-alpha ,business.industry ,Interleukin-8 ,Respiratory disease ,Infant, Newborn ,medicine.disease ,Trachea ,medicine.anatomical_structure ,Bronchopulmonary dysplasia ,Anesthesia ,Pediatrics, Perinatology and Child Health ,Breathing ,business ,Infant, Premature - Abstract
Ventilation with an inappropriate tidal volume (Vt) triggers lung inflammation, an important predisposing factor of bronchopulmonary dysplasia. It still remains uncertain what the appropriate starting target Vt should be during the acute phase of respiratory distress syndrome (RDS). Our aim was to evaluate lung inflammation in preterm infants undergoing synchronized intermittent positive-pressure ventilation (SIPPV) with two different tidal volumes Vt during the acute phase of RDS. Thirty preterm infants (gestational age, 25-32 weeks) with acute RDS were randomly assigned to be ventilated with Vt = 5 ml/kg (n = 15) or Vt = 3 ml/kg (n = 15). Proinflammatory cytokines (interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor (TNF)-alpha) were determined in the tracheal aspirate on days 1, 3, and 7 of life. IL-8 and TNF-alpha levels collected on day 7 were significantly higher (P < 0.05), and mechanical ventilation lasted longer in the group with Vt = 3 ml/kg (16.8 +/- 4 vs. 9.2 +/- 4 days; P = 0.05). In conclusion, our data show significantly higher lung inflammation in preterm infants ventilated with Vt = 3 ml/kg, suggesting a role for Vt = 5 ml/kg in reducing both inflammatory response during the acute phase of RDS and the length of ventilation. Whether the use of this starting Vt prevents bronchopulmonary dysplasia requires further study.
- Published
- 2006
11. A randomised, open label, controlled trial on the effect of interferon plus amantadine compared with interferon alone for treatment of chronic hepatitis C
- Author
-
Roberto Stellini, Maurizio Favret, Daniela Quattrocchi, A. Salmi, Marie Gracielle Pigozzi, Giovanni Andri, Alessandro Reggiani, Alberto Lanzini, Ornella Baisini, Franco Gargiulo, Anna Cominotti, and Federica Benini
- Subjects
medicine.medical_specialty ,Intention-to-treat analysis ,Hepatology ,medicine.drug_class ,business.industry ,Hepatitis C virus ,Amantadine ,medicine.disease_cause ,medicine.disease ,Gastroenterology ,law.invention ,Regimen ,Infectious Diseases ,Randomized controlled trial ,law ,Interferon ,Fibrosis ,Internal medicine ,Immunology ,medicine ,Antiviral drug ,business ,medicine.drug - Abstract
Background: Combination of the antiviral drug amantadine with interferon (IFN) may be more effective than IFN monotherapy for treatment of chronic hepatitis C. Methods: We randomised 93 patients with chronic hepatitis C to IFNIFN 6 MU 3 times/week for 24 weeks, followed by IFN 3 MU 3 times/week for further 24 weeks given in combination with amantadine 100 mg t.i.d. (regimen A, n=48) or as monotherapy (regimen B, n=45). Control liver biopsies were obtained 6 months post treatment. Results: At the end of the trial a similar proportion of patients had normal serum ALT levels (35% for regimen A, and 44% for regimen B) as measured by intention to treat criteria. Sustained biochemical response at 6 months post treatment was 15 and 20%, and sustained virological response was 10 and 20% for regimen A and B, respectively. The effect on liver histology was also similar: the inflammatory components of the Knodell score decreased by 1.3±0.6 points for regimen A and by 1.6±0.6 for regimen B, and score for fibrosis remained unchanged with both regimens. Conclusions: Combination of IFN therapy with amantadine does not enhance the effect of IFN as shown by biochemical, virological and histological criteria.
- Published
- 2003
12. High prevalence of a screening-detected, HFE-unrelated, mild idiopathic iron overload in Northern Italy
- Author
-
Giovanni, Barosi, Laura, Salvaneschi, Maurizia, Grasso, Miryam, Martinetti, Monia, Marchetti, Umberto, Bodini, Alessandro, Reggiani, Francesco, D'Agostino, Giulio, Nalli, Alberto, Degiuli, Annalisa, De Silvestri, and Eloisa, Arbustini
- Subjects
Adult ,Family Health ,Male ,Iron Overload ,Adolescent ,Genotype ,Iron ,DNA Mutational Analysis ,Middle Aged ,Prevalence ,Humans ,Mass Screening ,Female ,Ireland - Abstract
In Italy, typical HFE mutations account for only 64% of the cases with overt hereditary hemochromatosis (HH), and a common HFE-unrelated disease was hypothesized.One thousand and fifty potential blood donors were screened by iron tests, C282Y and H63D HFE mutation analysis in a region in North Italy. Subjects with repeated fasting transferrin saturation of 45% or more and no secondary iron overload were defined as probands with idiopathic iron overload. To assess the inheritance of iron overload, relatives of probands were screened.The overall frequency of probands with idiopathic iron overload was 3.43% (95% confidence interval, 2.32 to 4.52). Of these, 8.4% had genotypes associated with HH (compound heterozygous for H63D/C282Y or homozygous for H63D HFE mutations), and 91.6% had atypical genotypes: 47.2% were heterozygous for C282Y or H63D HFE mutations, and 44.4% had wild type/wild type genotype. A family history of iron overload was proven in 33.3% of probands with atypical genotypes (1.04% of the overall population). Pedigree analysis excluded linkage of heterozygous HFE mutations with iron overload (cumulative lod score 2.41) and documented a recessive non-HLA-linked locus accounting for iron overload in wild type/wild type genotypes. None of the probands had clinical signs of iron accumulation; in males, serum ferritin positively correlated with age (r=0.63, p0.01), and the regression model predicted a serum ferritin of 700 ng/mL at the age of 58.In Northern Italy an HFE-unrelated, mild idiopathic iron overload is highly prevalent. A recessive locus accounts for iron overload in at least 1.04% of the overall population.
- Published
- 2002
13. S1930 Metabolic Factors and Inflammatory Changes Are Responsible for Increased Gamma-Glutamyltranspeptidase Level in Chronic Hepatitis C
- Author
-
Federica Benini, Luisa Bercich, Chiara Ricci, Alessandro Reggiani, A. Mora, Francesco Lanzarotto, Marie Graciella Pigozzi, Bruno Mario Cesana, Alessandro Pozzi, S. Bertolazzi, and Alberto Lanzini
- Subjects
Hepatology ,Chronic hepatitis ,business.industry ,Immunology ,Gastroenterology ,Medicine ,Gamma glutamyltranspeptidase ,business - Published
- 2008
14. Axillary versus peripheral blood levels of sialic acid, ferritin, and CEA in patients with breast cancer
- Author
-
Salvatore Catania, Renato Gandini, Elisa Locatelli, Ettore Cunietti, Alessandro Reggiani, and Massimo Monti
- Subjects
Adult ,Cancer Research ,medicine.medical_specialty ,Pathology ,Phosphocreatine ,Breast Neoplasms ,Gastroenterology ,Veins ,Breast cancer ,Carcinoembryonic antigen ,Internal medicine ,Biomarkers, Tumor ,Elbow ,Medicine ,Humans ,Axillary Vein ,Lymph node ,Tumor marker ,Aged ,biology ,L-Lactate Dehydrogenase ,business.industry ,Cancer ,Venous blood ,Blood Proteins ,Middle Aged ,medicine.disease ,Carcinoembryonic Antigen ,Ferritin ,medicine.anatomical_structure ,Oncology ,Ferritins ,biology.protein ,Sialic Acids ,Drainage ,business ,Axillary vein - Abstract
Serum levels of total sialic acid, carcinoembryonic antigen (CEA), ferritin, lactate dehydrogenase, and creatine phosphokinase were measured both in tumor drainage blood (axillary vein) and in peripheral blood obtained from 121 breast cancer patients during surgery. No significant differences between mean values in peripheral and tumor draining blood, between cancer patients and healthy controls, or between patients with or without axillary lymph node metastases were found for any of the markers. Both ferritin and CEA levels were higher in axillary and peripheral blood from patients with central breast cancer versus other sites but the difference was significant only for CEA (p less than 0.05). CEA levels were significantly higher (p less than 0.01) in patients with greater than 2 cm diameter carcinomas versus T1 stage patients in axillary but not in peripheral blood. When the cephalic vein was clamped before the axillary sample was taken, ferritin showed a significant increase (p less than 0.05). We conclude that measurement of sialic acid, CEA, and ferritin in axillary venous blood in breast cancer patients is not of clinical benefit, although further data are needed to clarify whether other advantages can be derived.
- Published
- 1990
15. Interferon (IFN) vs interferon + amantadine hydrochloride (IFN+A) for treatment of chronic hepatitis C: An ongoing multicentre randomized trial
- Author
-
MariaGrazia De Tavonatti, Roberto Stellini, Marie Gracielle Pigozzi, Alberto Lanzini, Giovanni Andri, Lam-berto Bettini, Luciana Distefano, A. Salmi, Alessandro Reggiani, and Ornella Baisini
- Subjects
Hepatology ,Chronic hepatitis ,Randomized controlled trial ,law ,Interferon ,business.industry ,Gastroenterology ,Amantadine Hydrochloride ,medicine ,Pharmacology ,business ,law.invention ,medicine.drug - Published
- 2000
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.